Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

计划入组 50 人 · 首次发布于 2022 年 3 月 15 日

Osia CPT Code Study

计划入组 20 人 · 首次发布于 2020 年 3 月 25 日

CPT and Smoking Cessation

计划入组 69 人 · 首次发布于 2013 年 7 月 17 日

CPT-60621

CPT-1550

CD123-CPT

University Of Sussex

United Kingdom

LOTUS PHARMACEUTICAL CO., LTD.

China

ImmunoGen, Inc.

United States

FDA Aligns with Enabled Therapeutics on CPT-021: Novel Targeted Therapy for Alzheimer's Disease

Avenzo's CDK2 Inhibitor AVZO-021 Shows Promising Activity in Breast and Ovarian Cancer Patients

Aisa Pharma's AISA-021 Shows Promise in Phase 2 Trial for Systemic Sclerosis-Associated Raynaud's Phenomenon